The Diabetes Control and Complications Trial (DCCT) demonstrated intensive insulin therapy reduces retinopathy, neuropathy, and nephropathy in T1DM [8, 9, 10, 11]. This evidence concerns the gene INS and type 1 diabetes mellitus.